Dave saw an improvement in its IBD SmartSelect Composite Rating Tuesday, from 94 to 97.
The revised score means the stock currently tops 97% of all other stocks in terms of key performance metrics and technical strength. Winning stocks often have a 95 or higher score in the early stages of a new price run, so that's a good item to have on your checklist when looking for the best stocks to buy and watch.
Dave is not currently near a proper buy zone. See if the stock goes on to form a new base and offer a new buying opportunity.
Lean How — And When — To Sell Stocks
The stock earns an 82 EPS Rating, meaning its recent quarterly and longer-term annual earnings growth tops 82% of all stocks.
Its Accumulation/Distribution Rating of D- shows moderate selling by institutional investors over the last 13 weeks. Look for the rating to improve to at least a C or better.
In Q4, the company posted 278% earnings growth. Revenue growth came in at 38%, down from 41% in the previous quarter.
Dave holds the No. 2 rank among its peers in the Computer-Technical Services industry group. IBEX is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
